Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation

被引:116
作者
Song, Diane H.
Getty-Kaushik, Lisa
Tseng, Eva
Simon, Jonathan
Corkey, Barbara E.
Wolfe, M. Michael
机构
[1] Boston Med Ctr, Gastroenterol Sect, Dept Med, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
关键词
D O I
10.1053/j.gastro.2007.09.005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: in addition to its role as the primary mediator of the enteroinsular axis, glucose-dependent insulinotropic polypeptide (GIP) may play a critical role in the development of obesity. The purpose of these studies was to characterize the effects of GIP and its receptor (GIPR) in adipocyte development and signaling. Methods: Effects of GIP and GIPR on differentiated 3T3-L1 cells were analyzed using Western blot analysis, Oil-Red-O staining, cyclic adenosine monophosphate radioinummoassay, immunofluorescence microscopy, and glucose uptake measurements. Results: To determine whether GIP and GIPR are important components in adipocyte development, the expression profile of GIPR during differentiation was examined. GIPR protein expression was enhanced during the differentiation process, and coincubation with its ligand GIP augmented the expression of aP2, a fat cell marker. Conversely, the suppression of GIPR expression by a specific short hairpin RNA attenuated Oil-Red-O staining and aP2 expression, suggesting that the GIPR may play a critical role in adipocyte development. To investigate specific signaling components that may mediate the effects of GIP, we analyzed Akt, glucose transporter-4, and glucose uptake, all of which are modulated by insulin in fat cells. Like insulin, GIP induced the activation of Akt in a concentration-dependent manner, promoted membrane glucose transporter-4 accumulation, and enhanced [H-3]-2-deoxyglucose uptake. Conclusions: These studies provide further evidence for an important physiologic role for GIP in lipid homeostasis and possibly in the pathogenesis of obesity. Furthermore, our data indicate that the GIPR might represent a suitable target for the treatment of obesity.
引用
收藏
页码:1796 / 1805
页数:10
相关论文
共 46 条
  • [1] Ausubel FM, 1995, SHORT PROTOCOLS MOL
  • [2] IMMUNOREACTIVE GASTRIC-INHIBITORY POLYPEPTIDE AND K-CELL HYPERPLASIA IN OBESE HYPERGLYCEMIC (OB/OB) MICE FED HIGH-FAT AND HIGH-CARBOHYDRATE CAFETERIA DIETS
    BAILEY, CJ
    FLATT, PR
    KWASOWSKI, P
    POWELL, CJ
    MARKS, V
    [J]. ACTA ENDOCRINOLOGICA, 1986, 112 (02): : 224 - 229
  • [3] Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance
    Blüher, M
    Michael, MD
    Peroni, OD
    Ueki, K
    Carter, N
    Kahn, BB
    Kahn, CR
    [J]. DEVELOPMENTAL CELL, 2002, 3 (01) : 25 - 38
  • [4] Fat depot origin affects fatty acid handling in cultured rat and human preadipocytes
    Caserta, F
    Tchkonia, T
    Civelek, VN
    Prentki, M
    Brown, NF
    McGarry, JD
    Forse, RA
    Corkey, BE
    Hamilton, JA
    Kirkland, JL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 280 (02): : E238 - E247
  • [5] Clements RH, 2004, AM SURGEON, V70, P1
  • [6] Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells
    Cong, LN
    Chen, H
    Li, YH
    Zhou, LX
    McGibbon, MA
    Taylor, SI
    Quon, MJ
    [J]. MOLECULAR ENDOCRINOLOGY, 1997, 11 (13) : 1881 - 1890
  • [7] GASTRIC INHIBITORY POLYPEPTIDE (GIP) IN MATURITY-ONSET DIABETES-MELLITUS
    CROCKETT, SE
    MAZZAFERRI, EL
    CATALAND, S
    [J]. DIABETES, 1976, 25 (10) : 931 - 935
  • [8] CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758
  • [9] STIMULATION OF INSULIN-SECRETION BY GASTRIC INHIBITORY POLYPEPTIDE IN MAN
    DUPRE, J
    ROSS, SA
    WATSON, D
    BROWN, JC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1973, 37 (05) : 826 - 828
  • [10] GASTRIC-INHIBITORY POLYPEPTIDE ENHANCED LIPOPROTEIN-LIPASE ACTIVITY IN CULTURED PREADIPOCYTES
    ECKEL, RH
    FUJIMOTO, WY
    BRUNZELL, JD
    [J]. DIABETES, 1979, 28 (12) : 1141 - 1142